European Medicines Agency/International Federation for Animal Health-Europe info day 2015

• Date:
  Thursday, 12 March 2015, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

The info day covers the latest developments in the scientific review, regulation and marketing authorisation procedure. It is an opportunity for professionals to get first-hand information on current developments in the veterinary regulatory scene. Registration closed.

Documents

Programme - European Medicines Agency/International Federation for Animal Health-Europe info day 2015

Registration form - European Medicines Agency/International Federation for Animal Health-Europe info day 2015

Presentation - CVMP work plan for 2015: Highlights and potential implications for new applications and developments (Anja Holm)

Presentation - The latest developments in scientific review, regulation and marketing authorisation procedures: Update on specific points from Immunologicals Working Party (Esther Werner)

Presentation - Update from the CVMP's Environmental Risk Assessment Working Party: Assessment of veterinary medicinal products (VMPs) containing persistent, bioaccumulative and toxic substances (PBTs) (Boris Kolar)

Presentation - European Medicines Agency advice on the impact of the use of antibiotics on public and animal health: Potential impact on the authorisation of antimicrobials (Helen Jukes)

Presentation - Innovation in veterinary medicines in Europe including antibiotics (Erik De Ridder)

Presentation - Novel therapies: Innovation Task Force (ITF), scientific advice and new Ad Hoc group on Veterinary Novel Therapies (ADVENT) (Fia Westerholm)

Presentation - Minor-use-minor-species (MUMS) policy: An update (Kornelia Grein)

Presentation - Minor-use-minor-species (MUMS) policy: Industry feedback (Ludwig Klostermann)

Presentation - e-Submission roadmap: Veterinary perspective (Anne-Christine Lantin)

Presentation - Active substance master file procedure (Isabel Ugalde)

Presentation - Signal detection: Experience to date (Jos Olaerts)

Presentation - Establishing a signal management process: Experience to date with new procedures (Karen Quine)

Presentation - Procedural updates and organisation: Update on variations and progress in work-sharing (Melanie Leivers)

Presentation - Work sharing variations (Gavin Hall)

Presentation - Progress update: CMDv/Industry Joint Task Force on variations (Kevin Yount)

Presentation - European Medicines Agency reorganisation (Kornelia Grein)

Presentation - European Medicines Agency communication strategy: Strategic planning for the future and vision for veterinary medicines (Marie-Agnes Heine)